Pharmena S.A. (WSE:PHR)

Pharmena Statistics

Total Valuation

Pharmena has a market cap or net worth of PLN 37.53 million. The enterprise value is 37.53 million.

Market Cap	37.53M
Enterprise Value	37.53M

Important Dates

The next estimated earnings date is Tuesday, November 25, 2025.

Earnings Date	Nov 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Pharmena has 11.14 million shares outstanding.

Current Share Class	11.14M
Shares Outstanding	11.14M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	1.86%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	42.22
PB Ratio	3.34
P/TBV Ratio	3.78
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-17.95
EV / Sales	42.21
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-16.84

Financial Position

The company has a current ratio of 13.18, with a Debt / Equity ratio of 0.02.

Current Ratio	13.18
Quick Ratio	0.83
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.09
Interest Coverage	-267.17

Financial Efficiency

Return on equity (ROE) is -17.73% and return on invested capital (ROIC) is -16.74%.

Return on Equity (ROE)	-17.73%
Return on Assets (ROA)	-15.57%
Return on Invested Capital (ROIC)	-16.74%
Return on Capital Employed (ROCE)	-28.17%
Revenue Per Employee	127,000
Profits Per Employee	-298,714
Employee Count	7
Asset Turnover	0.07
Inventory Turnover	1.66

Taxes

Income Tax	-498,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.96% in the last 52 weeks. The beta is 0.47, so Pharmena's price volatility has been lower than the market average.

Beta (5Y)	0.47
52-Week Price Change	-37.96%
50-Day Moving Average	3.50
200-Day Moving Average	3.88
Relative Strength Index (RSI)	42.35
Average Volume (20 Days)	1,287

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharmena had revenue of PLN 889,000 and -2.09 million in losses. Loss per share was -0.19.

Revenue	889,000
Gross Profit	-83,000
Operating Income	-3.21M
Pretax Income	-2.59M
Net Income	-2.09M
EBITDA	-3.17M
EBIT	-3.21M
Loss Per Share	-0.19

Balance Sheet

The company has 209,000 in cash and 202,000 in debt, giving a net cash position of 7,000 or 0.00 per share.

Cash & Cash Equivalents	209,000
Total Debt	202,000
Net Cash	7,000
Net Cash Per Share	0.00
Equity (Book Value)	11.23M
Book Value Per Share	1.01
Working Capital	9.70M

Cash Flow

In the last 12 months, operating cash flow was -1.97 million and capital expenditures -263,000, giving a free cash flow of -2.23 million.

Operating Cash Flow	-1.97M
Capital Expenditures	-263,000
Free Cash Flow	-2.23M
FCF Per Share	-0.20

Margins

Gross margin is -9.34%, with operating and profit margins of -360.63% and -235.21%.

Gross Margin	-9.34%
Operating Margin	-360.63%
Pretax Margin	-291.23%
Profit Margin	-235.21%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.85, which amounts to a dividend yield of 25.37%.

Dividend Per Share	0.85
Dividend Yield	25.37%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	25.37%
Earnings Yield	-5.57%
FCF Yield	-5.94%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pharmena has an Altman Z-Score of 34.18 and a Piotroski F-Score of 4.

Altman Z-Score	34.18
Piotroski F-Score	4